Avapro Related Clinical Trials
Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension [Completed]
A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin [Recruiting]
Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice [Completed]
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy [Recruiting]
Irbesartan and Adhesion Molecules in AF [Recruiting]
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia [Recruiting]
Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan [Recruiting]
Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) [Completed]
Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing [Active, not recruiting]
Irbesartan Versus Amlodipine: The OBI Study [Not yet recruiting]
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan [Recruiting]
Irbesartan in Hypertension [Completed]
AMISH : Aprovel for Management of Isolated Systolic Hypertension [Completed]
Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome [Completed]
Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria [Completed]
Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol [Completed]
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Completed]
Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria [Completed]
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) [Active, not recruiting]
I PREVENT - Irbesartan In Hypertensive Diabetic Patients [Recruiting]
I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy [Recruiting]
I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients [Completed]
Combined Antihypertensive Therapy and Sexual Dysfunction [Recruiting]
Irbesartan in Type 2 Diabetes [Completed]
The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects [Completed]
Irbesartan and Amlodipine Combination in Controlling Blood Pressure [Recruiting]
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C [Recruiting]
Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria [Active, not recruiting]
Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers [Not yet recruiting]
Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With Hypertension [Completed]
A Randomized, Double-Blind, Study to Explore the Efficacy and Safety of RE-021 in Focal Segmental Glomerulosclerosis [Not yet recruiting]
Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study) [Recruiting]
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy [Recruiting]
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) [Active, not recruiting]
APROVE : Irbesartan in Hypertension [Completed]
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria [Completed]
Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin. [Completed]
Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure [Completed]
Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions [Completed]
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension [Completed]
The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension [Completed]
ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation [Completed]
Irbesartan and Atenolol in Hypertensive Heart Disease [Completed]
VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-Term Hemodialysis [Completed]
Jiangzhuo Qinggan Prescription and Irbesartan in the Treatment of Essential Hypertension(Hepatogastric Damp-heat)Clinical Study [Not yet recruiting]
Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia [Completed]
A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus [Recruiting]
Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients [Recruiting]
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension [Recruiting]
A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mg [Completed]
ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination [Recruiting]
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) [Recruiting]
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts [Recruiting]
Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. [Completed]
The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension [Recruiting]
Nephropathy In Type 2 Diabetes and Cardio-Renal Events [Active, not recruiting]
A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension [Recruiting]
Prevention of Kidney Transplant Rejection [Completed]
Role of AT1-Receptor Blockers in Insulin-Induced Vasodilation. [Recruiting]
Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney [Completed]
Preeclampsia: A Marker for Future Cardiovascular Risk in Women [Recruiting]
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment [Recruiting]
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) [Terminated]
Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) [Active, not recruiting]
Evaluating the Link Between Thiazide Medications, the Nervous System, and Diabetes in Individuals With High Blood Pressure [Recruiting]
PHARES Study: Management of Resistant Hypertension [Recruiting]
Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.
Sulodexide to Treat Type 2 Diabetic Nephropathy
Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia [Not yet recruiting]
Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics [Recruiting]
Comparison Study of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol [Recruiting]
High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy [Completed]
Adalat ® XL® vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients [Recruiting]
Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy [Completed]
Renal Denervation in Diabetic Nephropathy [Recruiting]
Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients [Recruiting]
|
